The global market for cell counting is projected to have considerable CAGR of around 7.4% during the forecast period. The major factor that driving the global cell counting market is the rising investment by the pharmaceutical companies and research institutes for the cell based research across the globe. This results primarily due to the increasing prevalence of cancer and the need for effective treatment therapy for cancer patients. For instance, in October 2017, the Stem Cell Network (SCN) has introduced a new funding competition of around $100 million, to provide support for high-quality translational and clinical trials in regenerative medicine and stem cell research. The funding is intended to support novel researches that will support to realize economic and health benefits to the Canadians.
A full report of Global Cell Counting Market is available at: https://www.omrglobal.com/industry-reports/cell-counting-market
Moreover, the growing popularity of cell culture in drug discovery, cancer treatment, and vaccine production has encourage the funding of cell-based research. However, the funds required for cell-based research is high due to which funding for these researches have been encouraged in a very few of the developed countries such as the US and UK. Decades of investment in research has made the US a one of the leading country in biological and Medical Science. Most of the success is due to the public/private funding partnership such as state governments of developed economies have put forward money in the form of initiatives in order to attract cell research so that the states may gain benefits of this promising technology.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cell-counting-market
In the US, private funds generally come from pharmaceutical companies that fund trials to list their own products. More than 83% of National Institute of Health (NIH) funds are distributed through competitive grants to over 300,000 scientists employed at universities, medical schools, and other research institutions in all 50 states of the country. For instance, in 2016, the NIH, the largest federal agency, spent half of the biomedical funds on cell-based research. Research supported by NIH has further extended the understanding of the molecular roots of various cancers and led to important awareness as to how microbial communities affect a range of chronic diseases including obesity and diabetes. It has led to the development of innovative technologies and created entirely new global biotechnology and life sciences industries that drive the cell counting market.
The investment in biomedical research funded by NIH has supported discoveries that lowered mortality from various chronic diseases such as cancer and CVD. NIH-funded research is continuing to produce the awareness that is needed for improvements in the healthcare sector in the near future. NIH major research funding was on immunotherapy, which uses human cells to improve cancer treatment options and creating organ-on-a-chip through a series of micro-chambers, fluids, and human cell to stimulate a person’s internal organs.Therefore, the funding on cell-based research increases, the opportunities for augmentation of cell counting market are estimated to grow significantly in the near future.
Global Cell Counting Market Segmentation
By Product Type
- Instruments
- Consumables
By Application
- Medical Applications
- Research
- Industrial
By End-User
- Pharmaceuticals and Biotechnology companies
- Research Institutes and CRO
- Hospitals and Diagnostic Laboratories
